Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
Conditions: Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Kidney Cancer; Renal Carcinoma; Kidney Cancer Metastatic Intervention: Drug: Olaparib Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Cancer | Cancer & Oncology | Carcinoma | Gastroschisis Repair | Genetics | Kidney Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology